Defective TGFβ signaling in cancer cells, mostly through the inactivation of TGFβRII in MSI CRC or SMAD4 in non-hypermutated CRC, is a frequent event that has been implicated in CRC progression. This evidence concerns the gene TGFB1 and colorectal carcinoma.